Kangmei Pharmaceutical Co., Ltd. (600518.SS) SHH
1.52
-0.02(-1.30%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 26.41B |
| Enterprise Value | 25.51B |
| P/E Ratio | -1,707.89 |
| PEG Ratio | 6.1 |
| Price/Sales Ratio | 4.19 |
| Price/Book Ratio | 3.46 |
| Enterprise/Revenue | 3.97 |
| Enterprise/EBITDA | -168.64 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0 |
| Operating Margin | -0.05 |
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0 |
Income Statement
| Revenue | 5.24B |
| Revenue/Share | 0.3 |
| Gross Profit | 839.72M |
| EBITDA | 159.39M |
| Net Income | 10.33M |
| Diluted EPS | 0 |
Balance Sheet
| Total Cash | 1.23B |
| Total Cash/Share | 0.07 |
| Total Debt | 150.16M |
| Total Debt/Equity | 0.02 |
| Current Ratio | 1.27 |
| Book Value Per Share | 0.44 |
Price History
| 52-Week Change | -22.05 |
| 52-Week High | 2.27 |
| 52-Week Low | 1.5 |
| Moving Average 50 Days | 1.69 |
| Moving Average 200 Days | 1.91 |
Statistics
| Average Volume | 178.45M |
| Shares Outstanding | 13.83B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | June 16, 2015 |
